(IWB) Russell 1000 - Overview
Etf: Large-Cap, Equity, Index, Blend, Benchmark
Dividends
| Dividend Yield | 1.09% |
| Yield on Cost 5y | 1.86% |
| Yield CAGR 5y | 6.68% |
| Payout Consistency | 98.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 12.5% |
| Relative Tail Risk | 4.51% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.61 |
| Alpha | -0.58 |
| Character TTM | |
|---|---|
| Beta | 0.959 |
| Beta Downside | 0.960 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.09% |
| CAGR/Max DD | 1.05 |
Description: IWB Russell 1000 January 28, 2026
The iShares Russell 1000 ETF (NYSE ARCA:IWB) tracks the Russell 1000 Index, investing at least 80 % of its net assets in the index’s component stocks and allowing up to 20 % in futures, options, swaps, cash, and cash equivalents. Because the fund’s holdings are concentrated in the 1,000 largest U.S. equities, it is classified as a non-diversified, large-blend ETF.
Key up-to-date metrics (as of 28 January 2026):
• Assets under management ≈ $71 billion, placing IWB among the top-10 U.S. equity ETFs.
• Expense ratio 0.15 % (net), unchanged from the prior year.
• Top five holdings ≈ Apple (AAPL) 5.2 %, Microsoft (MSFT) 4.8 %, Amazon (AMZN) 4.3 %, Alphabet Class A (GOOGL) 3.9 %, and Tesla (TSLA) 2.7 % of assets.
• Sector exposure is dominated by Technology (~25 % of assets), followed by Health Care (~13 %) and Consumer Discretionary (~12 %).
• Year-to-date total return ≈ 7.4 % versus the Russell 1000’s 7.1 %, reflecting modest outperformance amid a low-growth macro environment.
Given the ETF’s heavy tilt toward large-cap tech, its performance is especially sensitive to U.S. corporate earnings trends and Federal Reserve policy on interest rates; a sustained rise in rates could compress valuations in growth-oriented holdings.
For a deeper, factor-based view of how IWB’s risk and return profile may evolve, you might explore the analytics on ValueRay.
What is the price of IWB shares?
Over the past week, the price has changed by +0.10%, over one month by +0.60%, over three months by +1.94% and over the past year by +14.63%.
Is IWB a buy, sell or hold?
What are the forecasts/targets for the IWB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 441.7 | 16.7% |
IWB Fundamental Data Overview February 02, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 46.24b USD (46.24b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 46.24b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 46.24b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.45% (E(46.24b)/V(46.24b) * Re(9.45%) + (debt-free company))
Discount Rate = 9.45% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)